Your browser doesn't support javascript.
loading
Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials.
Mütze, Tobias; Salem, Susanna; Benda, Norbert; Schmidli, Heinz; Friede, Tim.
Afiliação
  • Mütze T; Statistical Methodology, Novartis Pharma AG, Basel, Switzerland.
  • Salem S; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Benda N; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Schmidli H; Biostatistics and Special Pharmacokinetics Unit, Federal Institute for Drugs and Medical Devices, Bonn, Germany.
  • Friede T; Statistical Methodology, Novartis Pharma AG, Basel, Switzerland.
Stat Med ; 39(27): 3968-3985, 2020 11 30.
Article em En | MEDLINE | ID: mdl-32815175
ABSTRACT
Blinded sample size re-estimation and information monitoring based on blinded data has been suggested to mitigate risks due to planning uncertainties regarding nuisance parameters. Motivated by a randomized controlled trial in pediatric multiple sclerosis (MS), a continuous monitoring procedure for overdispersed count data was proposed recently. However, this procedure assumed constant event rates, an assumption often not met in practice. Here we extend the procedure to accommodate time trends in the event rates considering two blinded approaches (a) the mixture approach modeling the number of events by a mixture of two negative binomial distributions and (b) the lumping approach approximating the marginal distribution of the event counts by a negative binomial distribution. Through simulations the operating characteristics of the proposed procedures are investigated under decreasing event rates. We find that the type I error rate is not inflated relevantly by either of the monitoring procedures, with the exception of strong time dependencies where the procedure assuming constant rates exhibits some inflation. Furthermore, the procedure accommodating time trends has generally favorable power properties compared with the procedure based on constant rates which stops often too late. The proposed method is illustrated by the clinical trial in pediatric MS.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Esclerose Múltipla Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Esclerose Múltipla Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article